2024-09-28 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instrumentation, reagents, consumables, and software for life sciences, analytical, and applied markets.

**1. Performance & Relative Strength:**

* **Cumulative Return:** TMO has delivered a cumulative return of 255.04% over the analyzed period, significantly outperforming the S&P 500 (VOO) which returned 134.22%.
* **Outperformance:** The current outperformance gap is 120.82%, ranking at the 55.67% percentile compared to its historical range. This indicates that TMO has consistently outperformed the S&P 500, but the recent outperformance is in the middle ground compared to its historical levels.

**2. Recent Price Movement:**

* **Closing Price:** $619.33
* **5-day Moving Average:** $610.71
* **20-day Moving Average:** $612.99
* **60-day Moving Average:** $592.91

The recent price action shows a slight upward trend. The stock is currently trading above its 5-day and 20-day moving averages, suggesting short-term bullish momentum. However, the 60-day moving average is below the current price, indicating a potential for price correction in the medium-term.

**3. Technical Indicators:**

* **RSI:** 54.87, indicating a neutral sentiment.
* **PPO:** -0.22, suggesting a slight bearish momentum.
* **Delta_Previous_Relative_Divergence:** -1.56, indicating a recent decline in relative strength.
* **Expected Return:** 19.52%, representing a 5-year projected return based on current investment amount. 

The technical indicators paint a mixed picture. While the RSI suggests a neutral sentiment, the PPO and relative divergence show some bearish momentum.  The projected return indicates potential for future growth.

**4. Recent Earnings & Future Prospects:**

| Date       | EPS    | Revenue        |
|------------|--------|-----------------|
| 2024-08-02 | 4.05   | 10.54 B$        |
| 2024-05-03 | 3.47   | 10.35 B$        |
| 2023-11-03 | 4.44   | 10.57 B$        |
| 2023-08-04 | 3.53   | 10.69 B$        |
| 2024-08-02 | 3.53   | 10.69 B$        |

The most recent earnings report shows a positive trend in both earnings per share (EPS) and revenue.  While the company's EPS was slightly lower than the previous quarter, the overall performance continues to show strong growth.  The future outlook for the company remains promising, with continued growth expected in the life sciences, analytical, and applied markets. 

**5. News & Recent Issues:**

* **Recent Market Outlook:** The market outlook for TMO remains positive, with analysts citing strong growth potential in its core markets. The company's focus on innovation, product development, and market expansion is driving its continued success. 
* **Analyst Opinions & Performance Highlights:**  According to analysts, TMO is well-positioned for long-term growth.  Its strong financial performance, robust product portfolio, and strategic acquisitions have contributed to its success and continue to fuel investor confidence. 

**6. Summary:**

Thermo Fisher Scientific Inc. (TMO) is a strong performer with a consistent track record of outperforming the market. The company's solid financial performance, strong technical indicators, and favorable market outlook suggest a promising future. While the recent price action indicates potential for some short-term correction, the long-term outlook for the company remains bullish.

**7. Disclaimer:** This report is provided for informational purposes only and should not be considered as investment advice. It is crucial to conduct your own research and consult with a qualified financial professional before making any investment decisions. 
